Bob,
One of the trials cited by PGS accepted only "non-smokers". Another one was all Chinese patients. And, as FTM quickly noted, the improvements over control were small, if any. If you want to, you can pull out the same arguments the BV board always brings out about international bias, subset groupings, not stat sig, etc. It's all just garbage and not really worth the effort. I really did however appreciate his lecture noting how other companies with enthusiastic board followings had failed. What a novel concept. Please thank him for his concern. It warms the cockles.
Regards,
WH
Ps - any idea why he is "poor", but giving investing advice? Dew seems to think he's a god. Good pairing.